Medcis Pathlabs India Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.56 Cr
as on 16-11-2024
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 7.50 M
as on 16-11-2024
- Revenue -26.08%
(FY 2023)
- Profit -87.98%
(FY 2023)
- Ebitda -64.68%
(FY 2023)
- Net Worth 7.20%
(FY 2023)
- Total Assets 6.56%
(FY 2023)
About Medcis Pathlabs India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.56 Cr.
The company has closed loans amounting to ₹7.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sandeep Sharma, Neha Saraf, and Ramoji Tejomurtula serve as directors at the Company.
- CIN/LLPIN
U85110TG2010PTC070969
- Company No.
070969
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Oct 2010
- Date of AGM
09 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Medcis Pathlabs India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neha Saraf  | Director | 29-Nov-2022 | Current |
| Sandeep Sharma | Director | 11-Mar-2022 | Current |
| Ramoji Tejomurtula | Director | 11-Mar-2022 | Current |
Financial Performance and Corporate Structure Insights of Medcis Pathlabs India.
Medcis Pathlabs India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.08% decrease. The company also saw a substantial fall in profitability, with a 87.98% decrease in profit. The company's net worth moved up by a moderate rise of 7.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medcis Pathlabs India?
In 2023, Medcis Pathlabs India had a promoter holding of 99.19% and a public holding of 0.81%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Healthmap Diagnostics Private LimitedActive 9 years 8 monthsNeha Saraf and Ramoji Tejomurtula are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 18 Sep 2020 | ₹7.50 M | Satisfied |
How Many Employees Work at Medcis Pathlabs India?
Medcis Pathlabs India has a workforce of 430 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medcis Pathlabs India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medcis Pathlabs India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
